Treatment persistence and maintenance dose titration among ulcerative colitis patients on biologics: a pooled study of three United States claim databases

IDENTIFYING INADEQUATE RESPONSE AMONG ULCERATIVE COLITIS PATIENTS ON AN ADVANCED THERAPY IN A REAL-WORLD ADMINISTRATIVE CLAIMS DATABASE

(2021) April Naegeli et al.   INFLAMMATORY BOWEL DISEASES

How to Optimize Treatment With Ustekinumab in Inflammatory Bowel Disease: Lessons Learned From Clinical Trials and Real-World Data

(2021) Ana Gutiérrez et al.   Frontiers in Medicine

Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: A narrative review

(2021) Alessandro Armuzzi et al.   DIGESTIVE AND LIVER DISEASE

Approach to the management of recently diagnosed inflammatory bowel disease patients: a user’s guide for adult and pediatric gastroenterologists

(2021) Manasi Agrawal et al.   GASTROENTEROLOGY

AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis

(2020) Joseph D. Feuerstein et al.   GASTROENTEROLOGY

DOP55 A real-world comparison of the effectiveness and safety of vedolizumab and anti-TNF therapies in early treatment initiation with first-line biologic therapy in ulcerative colitis: Results from EVOLVE

(2020) G Mantzaris et al.   Journal of Crohns & Colitis

Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe

(2020) Alessandro Armuzzi et al.   PLoS One

Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn’s disease patients: a German retrospective chart review

(2020) Ulf Helwig et al.   BMC GASTROENTEROLOGY

Real-World Experience with Tofacitinib in IBD at a Tertiary Center

(2019) Roni Weisshof et al.   DIGESTIVE DISEASES AND SCIENCES

ACG Clinical Guideline

(2019) David T. Rubin et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Variation Among Patients With Crohn’s Disease in Benefit vs Risk Preferences and Remission Time Equivalents

(2019) Meenakshi Bewtra et al.   Clinical Gastroenterology and Hepatology

Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases

(2019) Kellyn Moran et al.   ADVANCES IN THERAPY

Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease

(2019) Nisha B Shah et al.   INFLAMMATORY BOWEL DISEASES

Ulcerative colitis

(2017) Ryan Ungaro et al.   LANCET

Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States

(2017) Haridarshan Patel et al.   PLoS One

Ulcerative Colitis Treatment Patterns and Cost of Care

(2017) Kyle D. Null et al.   VALUE IN HEALTH

Inflammatory Bowel Disease Patients’ Willingness to Accept Medication Risk to Avoid Future Disease Relapse

(2015) Meenakshi Bewtra et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Ulcerative colitis: prevention of relapse

(2013) Makoto Naganuma et al.   Expert Review of Gastroenterology & Hepatology

Ulcerative colitis

(2012) Ingrid Ordás et al.   LANCET

Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

(2010) Asher Kornbluth et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY